Free Trial

The Recovery in Teladoc is Showing Signs of Life

Teledoc Stock price

Key Points

  • Teladoc Health provides members with non-urgent primary care, mental health and chronic care virtual health services.
  • Membership starts at $14.99 per month plus $75 or more per virtual visit or a co-pay with health insurance.
  • Teladoc has grown its provider network to over 7,000 board-certified doctors available 24/7 in all states in the U.S. and over 125 countries.
  • Teladoc expects to grow its members to 86 million in 2023.
  • Its BetterHealth mental health service revenues rose 18% YoY to $292.4 million.
  • Its Q2 2023 net loss was $65.2 million compared to $3.1 billion in Q2 2022, but $3.03 billion was a non-cash goodwill impairment charge.
  • Teladoc has been signing up with more insurance carriers to supplement its physician networks with its doctors and has grown its monthly access membership to over 56 million.
  • Teladoc plans to roll out its weight-loss and prediabetic management services with its physicians by Q3 2023.
  • Teladoc has integrated over 60 proprietary AI models to match its patients with the right doctors.
  • Teladoc shares have a 16.08% short interest.
  • 5 stocks we like better than Teladoc Health.

The world’s largest virtual healthcare services provider Teladoc Health Inc. NYSE: TDOC stock is finally breaking out of its year-long bearish weekly descending triangle pattern. The 20% jump in share prices within a week was triggered by its Q2 2023 earning report. While still operating in the red, the company is starting to experience positive normalization.

As people get more frustrated with the time it takes to make an in-person appointment with their primary care doctors, many are returning to the convenience and 24/7 access to the Teladoc Health platform.

The company has deployed over 60 proprietary artificial intelligence (AI) models to set appointments, match patients with providers, create personalized content and insights for its members and help the platform grow more efficiently. It has partnered with Microsoft Co. NASDAQ: MSFT to bring more Open.ai services to the platform.

BetterHealth Wildly Successful

Its embarkment into the mental health services segment was a game-changer that continues to pay dividends. It acquired the on-demand mental and behavioral health therapy and counseling platform Better Health in 2015 for just $4.5 million and now reaping over $1 billion in annual revenues. It recently grew its top line by 18% YoY with an annual run rate (ARR) to exceed $1.2 billion in 2023.

Why Teladoc?

At first glance, Teladoc seems like a farfetched idea for users to rely solely on telemedicine for their healthcare needs. Person-to-person doctor visits may be more reliable and trusted. However, in reality, an in-person appointment with a primary care doctor may take days to weeks to schedule via the traditional route.

Taking time out of your day and sitting through traffic and the waiting room adds to the total time to have an in-person appointment.

Access and Convenience 24/7

Teladoc streamlines this experience making access, personalization and convenience a top priority. Is it more comprehensive than an in-person visit? No. Is it convenient if you don't have the time to wait for a non-urgent doctor appointment? Yes.

For routine checkups, minor illnesses like the cold or flu, chronic conditions, mental health and specialist care, Teladoc fits the needs. With over 7,000 board-certified doctors available 24/7, it provides a good supplemental option to your healthcare needs.

Acceptance

During the pandemic, telemedicine was embraced by the world. This surged Teladoc stock up to $290 per share. The re-opening and the end of the pandemic have caused reality to set in, causing shares to plunge more than 90%. In-person doctor visits resumed back to normal. However, the normal can mean waiting days to weeks to schedule an opening with your primary care doctor, taking time off from work, waiting through traffic and waiting (sometimes even longer) in the waiting room to meet your doctor finally.

Stickiness

The convenience and access factor has caused Teladoc to remain "sticky" for pandemic users and new users. Teladoc has grown its network, and its insurance carriers have accepted the Teladoc network of providers as a supplemental network for its members. The negative normalization may finally be over as the positive normalization cycle commences, as evidenced by its recent earnings results. 

 

Growth Continues

On Jul 25, 2023, Teladoc released its fiscal second-quarter results for the quarter ending June 2023. The company reported an adjusted earnings-per-share (EPS) loss of 40 cents, excluding non-recurring items, versus consensus analyst estimates for a loss of 41 cents, beating estimates by 1 cent.

Net loss was $65.2 million compared to $3.1 billion in the year-ago period. This included most of a non-cash goodwill impairment chart of $3.03 billion. Stock-based compensation was $55.7 million, and restricting costs were $7.5 million. Adjusted EBITDA was $72.2 million. Revenues rose 10.1% year-over-year (YOY) to $652.41 million, beating analyst estimates for $649.2 million.

Segment Metrics

Its monthly membership access fees comprised the bulk of revenues, rising 11% to $575.7 million. Other revenues rose 4% to $76.7 million. Teladoc integrated health revenues rose 5% to $360.1 million.

The bulk of revenues were generated in the U.S., up 8% to $561.8 million. International revenues grew an impressive 28% to $90.6 million. BetterHelp had 18% YoY revenue growth to $292.3 million. Teladoc is seeing a spike in chronic care programs like its digital diabetes prevention program.

CEO Insights

Teladoc CEO Jason Gorevic commented, "First, the role of virtual care continues to grow. A recent market survey commissioned by Teladoc Health shows that three out of every four employers expect to spend more on virtual care over the next three years. This represents significant opportunities for our business.” He mentioned that the GLP-1 weight management program is set to launch later in the year, which will compete with WW International Inc. NASDAQ: WW, but Teladoc will be using licensed physicians versus WW’s clinicians.

The company has also embraced AI, leveraging over 60 proprietary AI models like its proprietary virtual care queuing system connecting over 10,000 patients to the right physicians daily. It uses AI models to match patients to therapists with better health.

Mixed Guidance

Teladoc expects Q3 2023 EPS for a loss of 40 to 50 cents versus a loss of 33 cents, consensus analyst estimates. Revenues for Q3 are expected between $650 million to $675 million versus $663.11 million consensus estimates. Full-year 2023 EPS losses are expected between $1.25 to $1.60 versus $1.31 analyst estimates. Revenue guidance was raised to $2.6 billion to $2.675 billion versus $2.62 billion consensus analyst estimates. This was a raise from previous revenue guidance of $2.575 billion to $2.675 billion.

Teladoc Health analyst ratings and price targets are at MarketBeat.

TDOC stock chart

 

Weekly Descending Triangle Breakout

TDOC has been in a year-long weekly descending triangle since peaking at $44.66 in July 2022. Shares took a tumultuous drop to $21.60 by January 2023. Each rally attempt was met by lower highs, forming the descending trendline, against a flat-bottom at $22.47. As TDOC gets closer to the apex, shares exploded though the $24.59 market structure low (MSL) trigger blowing past the 20-period exponential moving average (EMA) and the 50-period simple moving average (SMA) and at $26.67 and $25.31, respectfully. The weekly relative strength index (RSI) momentum oscillator finally bounced through the 50-band after rejecting three times since November 2022. Pullback support levels are $26.31, $24.59, $23.32 and $22.47.

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Jea Yu
About The Author

Jea Yu

Contributing Author

Trading Strategies

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Teladoc Health (TDOC)
2.8079 of 5 stars
$10.58-0.2%N/A-1.83Hold$12.24
Microsoft (MSFT)
4.8236 of 5 stars
$448.99+1.3%0.74%37.05Moderate Buy$504.36
Teladoc Health (IPOA)N/A$11.79flatN/AN/AN/AN/A
WW International (WW)
1.959 of 5 stars
$1.54-6.7%N/A-0.27Hold$4.50
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

GameStop’s Cash Pile Grows: Will This Be Enough to Save the Company?
3 High Short Interest Stocks You Need to Watch
SoundHound: The AI Stock That’s Up 100% – Could It Double Again Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines